The Centers for Disease Control and Prevention is assisting in a multistate investigation on the use of contaminated non-sterile ultrasound gel for ultrasound-guided percutaneous procedures. Reports of Paraburkholderia fungorum detected in blood cultures from patients across multiple health care facilities prompted the investigation, and the CDC said it was aware of 40 confirmed cases of the bacteria in four states and two other countries as of May 8. Tests found at least two contaminated products under the MediChoice and ClearImage brands that are manufactured by NEXT Medical Products Company. The CDC provided a series of recommendations for health care providers to ensure patient safety and prevent potential outbreaks.

Headline
The AHA will host a webinar Sept. 30 at 2 p.m. ET, where behavioral health and pediatrics professionals will learn how two hospitals are engaging young…
Chairperson's File
Public
Hospitals and health systems —traditionally focused on acute care — are increasingly becoming more involved in primary care. There is tremendous value for…
Headline
The Health Resources and Services Administration has awarded approximately $7 million in grants to seven recipients in the fiscal year 2026 cohort of its Rural…
Headline
In a new blog by Aisha Syeda, senior program manager at AHA, learn how you can participate in the first Better Health for Mothers and Babies Awareness Week,…
Blog
Every mother and baby deserves the opportunity for a healthy start. Hospitals and health systems help make that possible by providing care throughout pregnancy…
Headline
A report released Sept. 21 by the Centers for Disease Control and Prevention found improvements in mental health and dietary habits among U.S. high school…